Nanomedicine and its potential in diabetes research and practice

J.C. Pickup, Z.L. Zhi, F. Khan, T. Saxl, D.J.S. Birch

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Nanomedicine involves measurement and therapy at the level of 1-100 nm. Although the science is still in its infancy, it has major potential applications in diabetes. These include solving needs such as non-invasive glucose monitoring using implanted nanosensors, with key techniques being fluorescence resonance energy transfer (FRET) and fluorescence lifetime sensing, as well as new nano-encapsulation technologies for sensors such as layer-by-layer (LBL) films. The latter might also achieve better insulin delivery in diabetes by both improved islet encapsulation and oral insulin formulations. An artificial nanopancreas could be an alternative closed-loop insulin delivery system. Other applications of nanomedicine include targeted molecular imaging in vivo (e.g. tissue complications) using quantum dots (QDs) or gold nanoparticles, and single-molecule detection for the study of molecular diversity in diabetes pathology
LanguageEnglish
Pages604-610
Number of pages6
JournalDiabetes-Metabolism Research and Reviews
Volume24
Issue number8
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Nanomedicine
Insulin
Research
Quantum Dots
Fluorescence Resonance Energy Transfer
Molecular Imaging
Gold
Nanoparticles
Fluorescence
Pathology
Technology
Glucose
Therapeutics

Keywords

  • nanomedicine
  • glucose sensors
  • fluorescence
  • nanoparticles
  • insulin
  • single-molecule

Cite this

@article{a7903b46f524465d8c2e9e4dd100b2f4,
title = "Nanomedicine and its potential in diabetes research and practice",
abstract = "Nanomedicine involves measurement and therapy at the level of 1-100 nm. Although the science is still in its infancy, it has major potential applications in diabetes. These include solving needs such as non-invasive glucose monitoring using implanted nanosensors, with key techniques being fluorescence resonance energy transfer (FRET) and fluorescence lifetime sensing, as well as new nano-encapsulation technologies for sensors such as layer-by-layer (LBL) films. The latter might also achieve better insulin delivery in diabetes by both improved islet encapsulation and oral insulin formulations. An artificial nanopancreas could be an alternative closed-loop insulin delivery system. Other applications of nanomedicine include targeted molecular imaging in vivo (e.g. tissue complications) using quantum dots (QDs) or gold nanoparticles, and single-molecule detection for the study of molecular diversity in diabetes pathology",
keywords = "nanomedicine, glucose sensors, fluorescence, nanoparticles, insulin, single-molecule",
author = "J.C. Pickup and Z.L. Zhi and F. Khan and T. Saxl and D.J.S. Birch",
year = "2008",
month = "11",
doi = "10.1002/dmrr.893",
language = "English",
volume = "24",
pages = "604--610",
journal = "Diabetes-Metabolism Research and Reviews",
issn = "1520-7552",
number = "8",

}

Nanomedicine and its potential in diabetes research and practice. / Pickup, J.C.; Zhi, Z.L.; Khan, F.; Saxl, T.; Birch, D.J.S.

In: Diabetes-Metabolism Research and Reviews, Vol. 24, No. 8, 11.2008, p. 604-610.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanomedicine and its potential in diabetes research and practice

AU - Pickup, J.C.

AU - Zhi, Z.L.

AU - Khan, F.

AU - Saxl, T.

AU - Birch, D.J.S.

PY - 2008/11

Y1 - 2008/11

N2 - Nanomedicine involves measurement and therapy at the level of 1-100 nm. Although the science is still in its infancy, it has major potential applications in diabetes. These include solving needs such as non-invasive glucose monitoring using implanted nanosensors, with key techniques being fluorescence resonance energy transfer (FRET) and fluorescence lifetime sensing, as well as new nano-encapsulation technologies for sensors such as layer-by-layer (LBL) films. The latter might also achieve better insulin delivery in diabetes by both improved islet encapsulation and oral insulin formulations. An artificial nanopancreas could be an alternative closed-loop insulin delivery system. Other applications of nanomedicine include targeted molecular imaging in vivo (e.g. tissue complications) using quantum dots (QDs) or gold nanoparticles, and single-molecule detection for the study of molecular diversity in diabetes pathology

AB - Nanomedicine involves measurement and therapy at the level of 1-100 nm. Although the science is still in its infancy, it has major potential applications in diabetes. These include solving needs such as non-invasive glucose monitoring using implanted nanosensors, with key techniques being fluorescence resonance energy transfer (FRET) and fluorescence lifetime sensing, as well as new nano-encapsulation technologies for sensors such as layer-by-layer (LBL) films. The latter might also achieve better insulin delivery in diabetes by both improved islet encapsulation and oral insulin formulations. An artificial nanopancreas could be an alternative closed-loop insulin delivery system. Other applications of nanomedicine include targeted molecular imaging in vivo (e.g. tissue complications) using quantum dots (QDs) or gold nanoparticles, and single-molecule detection for the study of molecular diversity in diabetes pathology

KW - nanomedicine

KW - glucose sensors

KW - fluorescence

KW - nanoparticles

KW - insulin

KW - single-molecule

UR - http://dx.doi.org/10.1002/dmrr.893

U2 - 10.1002/dmrr.893

DO - 10.1002/dmrr.893

M3 - Article

VL - 24

SP - 604

EP - 610

JO - Diabetes-Metabolism Research and Reviews

T2 - Diabetes-Metabolism Research and Reviews

JF - Diabetes-Metabolism Research and Reviews

SN - 1520-7552

IS - 8

ER -